"Holli Baumunk took over as president and CEO of the Colorado BioScience Association (CBSA) on July 12. She already was familiar with the state’s biotech drug and medical device companies from working as vice president of the Metro Denver Economic Development Corp.
A top priority of her first year will be working on creating a “fund of funds,” designed to supply capital to private venture funds investing in startup companies that commercialize Colorado technologies in the biotech drug, medical device, biofuel and clean technology fields. An industry road map prepared for the CBSA in 2008 recommended pushing for a $250 million “fund of funds” similar to ones in other states that use money from state employee pension funds and other investors."
Link to Greg Avery's profile of Holli Baumunk in today's DBJ